Aurinia Pharmaceuticals
AUPH
#5063
Rank
โ‚น109.92 B
Marketcap
โ‚น767.77
Share price
-0.11%
Change (1 day)
0.34%
Change (1 year)

Revenue for Aurinia Pharmaceuticals (AUPH)

Revenue in 2024 (TTM): โ‚น18.38 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น18.73 Billion. In 2023 the company made a revenue of โ‚น14.61 Billion an increase over the revenue in the year 2022 that were of โ‚น11.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aurinia Pharmaceuticals from 1999 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น18.38 B25.86%
2023 โ‚น14.61 B31.74%
2022 โ‚น11.09 B226.74%
2021 โ‚น3.39 B-7.39%
2020 โ‚น3.66 B16063.28%
2019 โ‚น22.67 M-29.95%
2018 โ‚น32.37 M21.01%
2017 โ‚น26.75 M127.57%
2016 โ‚น11.75 M-24.72%
2015 โ‚น15.61 M-11.36%
2014 โ‚น17.61 M-69.97%
2013 โ‚น58.66 M-82.36%
2012 โ‚น0.33 B565.07%
2011 โ‚น50.01 M-67.24%
2010 โ‚น0.15 B19.69%
2009 โ‚น0.12 B-32.19%
2008 โ‚น0.18 B117.33%
2007 โ‚น86.55 M-43.57%
2006 โ‚น0.15 B-1082.96%
2005 -โ‚น15.61 Million-129.05%
2004 โ‚น53.72 M-84.61%
2003 โ‚น0.34 B-40.07%
2002 โ‚น0.58 B
2000 โ‚น41.57 M-29.59%
1999 โ‚น59.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น1.177 T 6,183.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.53 B-97.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.66 B-91.12%๐Ÿ‡บ๐Ÿ‡ธ USA